Andrew Callos 10b5-1 sales reported for CYTK (NASDAQ: CYTK)
Rhea-AI Filing Summary
Andrew Callos reported multiple planned sales of Common Stock under a Rule 10b5-1 plan. The filing lists individual dispositions dated between 12/29/2025 and 03/09/2026, including transactions of 15,000 shares on 01/05/2026 and 15,000 shares on 02/05/2026, with listed proceeds for each trade. The transactions are described as 10b5-1 sales.
Positive
- None.
Negative
- None.
Insights
Insider executed scheduled 10b5-1 sales across multiple dates; pattern consistent with pre-arranged liquidity.
Andrew Callos reports a sequence of dispositions labeled as 10b5-1 Sales, with multiple entries of $928,062.00 for 03/05/2026 and similar amounts on other dates. The filing lists exact share counts and gross proceeds by date.
These entries reflect pre-arranged trading activity; cash‑flow treatment to the selling holder is clear from the schedule, and timing follows the plan dates shown in the excerpt.